Clinical Research Division, Brazilian National Cancer Institute (INCA), RJ;

Isabella Guimarães

Também publicou em: XIV SO 2020

Este é seu perfil? Faça login para acessar seus certificados
Trabalhos 1

  • PCA3 SILENCING SENSITIZES PROSTATE CANCER CELLS TO DOCETAXEL

    • 1 Program of Molecular Hemato-Oncology, Brazilian National Cancer Institute (INCA), RJ; Biomedical Institute, Federal Fluminense University (UFF), RJ; National School of Public Health Sergio Arouca, Oswaldo Cruz Foundation (FIOCRUZ), RJ;
    • 2 Clinical Research Division, Brazilian National Cancer Institute (INCA), RJ;
    • 3 Program of Molecular Hemato-Oncology, Brazilian National Cancer Institute (INCA), RJ; Biomedical Institute, Federal Fluminense University (UFF), RJ;
    • 4 Program of Molecular Hemato-Oncology, Brazilian National Cancer Institute (INCA), RJ; Biomedical Institute, Federal Fluminense University (UFF), RJ; Humanities and Health Institute, Federal Fluminense University (UFF), RJ, Brazil.
    Vol 3, 2022 -
    155118
    DR - Doctoral Student

Coautores(as) (3)

Publicações em outros proceedings